ACP Cure Acquisition
New York, US · Founded 2017 · Delaware LLC
Find your way into ACP Cure Acquisition
Sign up to see every warm intro you have to ACP Cure Acquisition
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ACP Cure Acquisition team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SV
SRIRAM VENKATARAMANNamed on SEC filing
JC
JOHN CAFASSONamed on SEC filing
BS
BENJAMIN SILBERTNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$135M disclosed across 1 round · 2017
▶$135MraisedJun 2017 · 27 investors · OtherRule 506(b)
▶$135MraisedJun 2017 · 27 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- SRIRAM VENKATARAMANExecutive Officer
- JOHN CAFASSOExecutive Officer
- BENJAMIN SILBERTExecutive Officer
- Offering amount
- $135M
- Amount sold
- $135M
- First sale
- Jun 2017
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ACP Cure Acquisition raised?
- ACP Cure Acquisition has disclosed $135M raised across 1 round.
- Where is ACP Cure Acquisition headquartered?
- ACP Cure Acquisition is headquartered in New York, US.